Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/96392
DC Field | Value | Language |
---|---|---|
dc.contributor | Department of Applied Biology and Chemical Technology | en_US |
dc.contributor | Innovation and Technology Development Office | en_US |
dc.creator | Chan, TH | en_US |
dc.creator | Wang, CC | en_US |
dc.date.accessioned | 2022-12-02T01:13:17Z | - |
dc.date.available | 2022-12-02T01:13:17Z | - |
dc.identifier.uri | http://hdl.handle.net/10397/96392 | - |
dc.language.iso | en | en_US |
dc.title | Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) for use in the treatment of endometriosis | en_US |
dc.type | Patent | en_US |
dc.description.otherinformation | US10646467; US10646467 B2; US10646467B2; US10,646,467; US10,646,467 B2; 10646467; Appl. No. 16/259620 | en_US |
dcterms.abstract | Method of treating endometriosis and related indications, comprising the administration of Pro-EGCG, a synthetic and derivative product of epigallocatechin-3-gallate [(−)-EGCG]. Use of PRO-EGCG in the manufacture of a medicament for treating endometriosis and related indications. Pro-EGCG for use in the treatment of endometriosis and related indications. | en_US |
dcterms.accessRights | open access | en_US |
dcterms.bibliographicCitation | US Patent 10,646,467 B2. Washington, DC: US Patent and Trademark Office, 2020 | en_US |
dcterms.issued | 2020-05-12 | - |
dc.description.country | US | - |
dc.description.validate | 202211 bcch | en_US |
dc.description.oa | Version of Record | en_US |
Appears in Collections: | Patent |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
us10646467b2.pdf | 1.63 MB | Adobe PDF | View/Open |
Page views
43
Last Week
0
0
Last month
Citations as of Sep 22, 2024
Downloads
15
Citations as of Sep 22, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.